The Promise of Combining Radiation Therapy With Immunotherapy
The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy age...
Saved in:
| Published in | International journal of radiation oncology, biology, physics Vol. 108; no. 1; pp. 6 - 16 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.09.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy agents, particularly in the setting of metastatic disease. The integration of immunotherapy into phase 3 clinical trial design has lagged in settings of advanced locoregional disease, where combination with radiation therapy may be critical. Yet, such may be the settings where immunotherapies have their greatest potential to affect patient survival and achieve curative outcomes. In this review, we discuss the interaction of radiation with the immune system and the potential to augment antitumor immunity through combined-modality approaches that integrate radiation and immunotherapies. The dynamics of cellular and tumor response to radiation offer unique opportunities for beneficial interplay with immunotherapy that may go unrecognized with conventional screening and monotherapy clinical testing of novel pharmaceutical agents. Using immune checkpoint blockade as a primary example, we discuss recent preclinical and clinical studies that illustrate the potential synergy of such therapies in combination with radiation, and we highlight the potential clinical value of such interactions. For various immunotherapy agents, their greatest clinical effect may rest in combination with radiation, and efforts to facilitate systematic investigation of this approach are highly warranted. |
|---|---|
| AbstractList | The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy agents, particularly in the setting of metastatic disease. The integration of immunotherapy into phase 3 clinical trial design has lagged in settings of advanced locoregional disease, where combination with radiation therapy may be critical. Yet, such may be the settings where immunotherapies have their greatest potential to affect patient survival and achieve curative outcomes. In this review, we discuss the interaction of radiation with the immune system and the potential to augment antitumor immunity through combined-modality approaches that integrate radiation and immunotherapies. The dynamics of cellular and tumor response to radiation offer unique opportunities for beneficial interplay with immunotherapy that may go unrecognized with conventional screening and monotherapy clinical testing of novel pharmaceutical agents. Using immune checkpoint blockade as a primary example, we discuss recent preclinical and clinical studies that illustrate the potential synergy of such therapies in combination with radiation, and we highlight the potential clinical value of such interactions. For various immunotherapy agents, their greatest clinical effect may rest in combination with radiation, and efforts to facilitate systematic investigation of this approach are highly warranted.The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy agents, particularly in the setting of metastatic disease. The integration of immunotherapy into phase 3 clinical trial design has lagged in settings of advanced locoregional disease, where combination with radiation therapy may be critical. Yet, such may be the settings where immunotherapies have their greatest potential to affect patient survival and achieve curative outcomes. In this review, we discuss the interaction of radiation with the immune system and the potential to augment antitumor immunity through combined-modality approaches that integrate radiation and immunotherapies. The dynamics of cellular and tumor response to radiation offer unique opportunities for beneficial interplay with immunotherapy that may go unrecognized with conventional screening and monotherapy clinical testing of novel pharmaceutical agents. Using immune checkpoint blockade as a primary example, we discuss recent preclinical and clinical studies that illustrate the potential synergy of such therapies in combination with radiation, and we highlight the potential clinical value of such interactions. For various immunotherapy agents, their greatest clinical effect may rest in combination with radiation, and efforts to facilitate systematic investigation of this approach are highly warranted. The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy agents, particularly in the setting of metastatic disease. The integration of immunotherapy into phase III clinical trial design has lagged in settings of advanced loco-regional disease where combination with radiotherapy may be critical. Yet such may be the settings where immunotherapies have their greatest potential to affect cancer patient survival and achieve curative outcomes. In this review, we discuss the interaction of radiation with the immune system and the potential to augment anti-tumor immunity through combined modality approaches that integrate radiation and immunotherapies. The dynamics of cellular and tumor response to radiation offer unique opportunities for beneficial interplay with immunotherapy that may go unrecognized with conventional screening and monotherapy clinical testing of novel pharmaceutical agents. Using immune checkpoint blockade as a primary example, we discuss recent preclinical and clinical studies that illustrate the potential synergy of such therapies in combination with radiation and we highlight the potential clinical value of such interactions. For various immunotherapy agents, their greatest clinical impact may rest in combination with radiation and efforts to facilitate systematic investigation of this approach are highly warranted. The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between tumor cells and immune cell populations. The past decade has brought an accelerating pace to the clinical investigation of new immunotherapy agents, particularly in the setting of metastatic disease. The integration of immunotherapy into phase 3 clinical trial design has lagged in settings of advanced locoregional disease, where combination with radiation therapy may be critical. Yet, such may be the settings where immunotherapies have their greatest potential to affect patient survival and achieve curative outcomes. In this review, we discuss the interaction of radiation with the immune system and the potential to augment antitumor immunity through combined-modality approaches that integrate radiation and immunotherapies. The dynamics of cellular and tumor response to radiation offer unique opportunities for beneficial interplay with immunotherapy that may go unrecognized with conventional screening and monotherapy clinical testing of novel pharmaceutical agents. Using immune checkpoint blockade as a primary example, we discuss recent preclinical and clinical studies that illustrate the potential synergy of such therapies in combination with radiation, and we highlight the potential clinical value of such interactions. For various immunotherapy agents, their greatest clinical effect may rest in combination with radiation, and efforts to facilitate systematic investigation of this approach are highly warranted. |
| Author | Harari, Paul M. Morris, Zachary S. Jagodinsky, Justin C. |
| Author_xml | – sequence: 1 givenname: Justin C. surname: Jagodinsky fullname: Jagodinsky, Justin C. – sequence: 2 givenname: Paul M. surname: Harari fullname: Harari, Paul M. – sequence: 3 givenname: Zachary S. surname: Morris fullname: Morris, Zachary S. email: zmorris@humonc.wisc.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32335187$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkV1LHDEYhYNYdLX9B1Lmsjcz5nNmU1pBlrYKQqUo9i5kknfcbGeSNZkV9t83ulux3uxVSPKc8ybnHKF9HzwgdEJwRTCpTxeVW8TQLiuKKa4wrzBle2hCpo0smRC_99EEsxqXLMOH6CilBcaYkIYfoENGGROZnKCvN3MormMYXIIidMUsDK3zzt8Xv7R1enTBFxmJerku7tw4Ly6HYeXDuDl6j951uk_wYbseo9vv325mF-XVzx-Xs_Or0ghSj6WmlnEGUvJWgqEWLK6h7UAIDTUnshVcCw60a4ARbG2tpybva2kpZpJIdozONr7LVTuANeDHqHu1jG7Qca2Cdur_G-_m6j48qoZz2hCeDT5tDWJ4WEEaVf6wgb7XHsIqKcqkoGJKOcvox9ezXob8yywDfAOYGFKK0L0gBKunatRCbapRT9UozFWuJss-v5EZNz4HnF_s-l3ibQCQU350EFUyDrwB6yKYUdngdhl8eWNg-tyz0f0fWO-W_wV7C8Gj |
| CitedBy_id | crossref_primary_10_3389_fonc_2021_663852 crossref_primary_10_1016_j_lungcan_2021_01_005 crossref_primary_10_31083_j_fbl2910349 crossref_primary_10_1002_btm2_10353 crossref_primary_10_3390_cancers14071677 crossref_primary_10_3390_cancers16173018 crossref_primary_10_1002_mabi_202100039 crossref_primary_10_3390_ijms22147755 crossref_primary_10_1016_j_cytogfr_2023_11_003 crossref_primary_10_1186_s13014_022_02038_x crossref_primary_10_1016_j_ijrobp_2022_03_030 crossref_primary_10_3390_cancers15010127 crossref_primary_10_1016_j_brachy_2020_10_012 crossref_primary_10_3390_cancers15225472 crossref_primary_10_1080_14656566_2021_1921149 crossref_primary_10_1200_EDBK_390290 crossref_primary_10_1002_cncr_33975 crossref_primary_10_1007_s12032_023_02060_3 crossref_primary_10_1016_j_trecan_2022_05_005 crossref_primary_10_1016_j_ejmech_2023_115911 crossref_primary_10_1016_j_semradonc_2021_09_001 crossref_primary_10_1136_jitc_2021_003730 crossref_primary_10_1002_path_5989 crossref_primary_10_3389_fphar_2021_746853 crossref_primary_10_3390_biomedicines11061642 crossref_primary_10_3390_vaccines11071275 crossref_primary_10_1146_annurev_immunol_101819_024752 crossref_primary_10_1007_s00262_022_03325_y crossref_primary_10_1016_j_ijrobp_2021_04_009 crossref_primary_10_1016_j_addr_2022_114367 crossref_primary_10_3390_cancers12051181 crossref_primary_10_1186_s12938_024_01263_7 crossref_primary_10_12677_ACM_2022_1291173 crossref_primary_10_3389_fonc_2024_1357790 crossref_primary_10_3390_ijms242316691 crossref_primary_10_3389_fonc_2024_1497351 crossref_primary_10_1038_s41598_021_86863_2 crossref_primary_10_1093_neuonc_noad184 crossref_primary_10_1016_j_neo_2021_09_003 crossref_primary_10_1186_s41181_025_00328_9 crossref_primary_10_1016_j_radonc_2023_109981 crossref_primary_10_1016_j_ctro_2024_100758 crossref_primary_10_3390_cells13231937 crossref_primary_10_1038_s41551_025_01360_5 crossref_primary_10_1016_j_ijrobp_2021_03_047 crossref_primary_10_1039_D3NR01050C crossref_primary_10_3390_cancers14133273 crossref_primary_10_1111_1754_9485_13398 crossref_primary_10_1109_OJEMB_2022_3163533 crossref_primary_10_1007_s10388_024_01067_7 crossref_primary_10_1016_j_jormas_2024_101846 crossref_primary_10_1080_14737140_2023_2173175 crossref_primary_10_1158_1078_0432_CCR_22_2746 crossref_primary_10_3390_ph17121591 crossref_primary_10_3390_cancers13020192 crossref_primary_10_1158_1535_7163_MCT_23_0215 crossref_primary_10_1039_D2CS00437B crossref_primary_10_3892_mco_2021_2376 crossref_primary_10_1016_j_adro_2024_101513 crossref_primary_10_3390_ijms21217935 crossref_primary_10_3390_pharmaceutics14112326 crossref_primary_10_1186_s13058_023_01671_y crossref_primary_10_3389_fimmu_2021_763888 crossref_primary_10_1016_j_eclinm_2023_102315 crossref_primary_10_1016_j_hfc_2022_02_012 crossref_primary_10_3390_pharmaceutics16040534 crossref_primary_10_32948_auo_2025_02_01 crossref_primary_10_1016_j_biopha_2024_116532 crossref_primary_10_1016_j_nwnano_2023_100003 crossref_primary_10_3389_fvets_2022_803093 crossref_primary_10_1371_journal_pone_0255798 crossref_primary_10_1158_1078_0432_CCR_21_4239 crossref_primary_10_1016_j_bas_2024_102912 crossref_primary_10_1002_adhm_202100814 crossref_primary_10_3390_cancers13174322 crossref_primary_10_1245_s10434_021_10987_y crossref_primary_10_3389_fonc_2021_647272 crossref_primary_10_1371_journal_pone_0273547 crossref_primary_10_1146_annurev_cancerbio_061421_040258 crossref_primary_10_1038_s41598_024_58684_6 crossref_primary_10_1186_s13045_021_01164_5 crossref_primary_10_1016_j_neo_2022_100864 crossref_primary_10_3389_froh_2023_1180869 crossref_primary_10_1515_ract_2023_0255 crossref_primary_10_1007_s11864_022_00989_7 crossref_primary_10_1186_s12885_022_10407_8 crossref_primary_10_3389_fonc_2021_637591 crossref_primary_10_1136_jitc_2022_005103 crossref_primary_10_3389_fonc_2021_766407 crossref_primary_10_1177_10732748241237331 crossref_primary_10_3389_fimmu_2023_1177085 crossref_primary_10_3390_cancers14163892 crossref_primary_10_1126_scitranslmed_adk0642 crossref_primary_10_2217_imt_2022_0041 crossref_primary_10_1186_s12967_021_03112_w crossref_primary_10_3389_fonc_2022_879391 crossref_primary_10_1186_s13046_021_01959_x crossref_primary_10_3389_fonc_2021_749496 crossref_primary_10_3390_cancers13205171 crossref_primary_10_1136_jitc_2022_006392 |
| Cites_doi | 10.1080/2162402X.2015.1021541 10.1016/S1470-2045(14)70189-5 10.1016/j.ijrobp.2007.01.041 10.1080/07357909909011718 10.1001/jamaoncol.2019.1478 10.1158/0008-5472.CAN-15-2644 10.1126/scitranslmed.3007646 10.1101/cshperspect.a028472 10.3389/fonc.2012.00191 10.1259/0007-1285-62-740-679 10.1038/s41467-017-01566-5 10.1093/annonc/mdx683 10.1186/1471-2164-10-625 10.1016/j.ijrobp.2003.09.012 10.1586/14760584.4.3.259 10.1038/s42003-019-0327-4 10.1158/1078-0432.728.11.2 10.1158/1078-0432.CCR-17-3279 10.1007/s00011-012-0567-y 10.1158/1078-0432.CCR-09-0265 10.1056/NEJMoa1709937 10.1093/annonc/mdz011 10.1371/journal.pmed.1000161 10.3389/fonc.2020.00084 10.1146/annurev-immunol-032712-100008 10.2307/3577549 10.1016/j.brachy.2018.07.004 10.1016/j.immuni.2014.10.019 10.1158/1078-0432.CCR-17-3427 10.1158/1541-7786.MCR-14-0689 10.3892/or_00001028 10.1016/j.adro.2018.08.014 10.1016/j.cell.2016.11.022 10.3109/07357900009012210 10.1073/pnas.86.24.10024 10.1038/cmi.2009.117 10.1080/15401420390844483 10.1016/j.ijrobp.2010.09.034 10.1053/j.seminoncol.2015.05.011 10.1016/j.cell.2017.09.048 10.1158/2326-6066.CIR-13-0082 10.1016/S1470-2045(17)30380-7 10.1158/1078-0432.CCR-16-1673 10.1038/nature23470 10.1093/annonc/mdv622 10.1186/s40425-016-0156-7 10.1200/JCO.1999.17.7.2105 10.1001/jamaoncol.2017.3993 10.4161/onci.28518 10.1126/scitranslmed.aaf0746 10.1001/jamaoncol.2019.2187 10.1073/pnas.89.4.1428 10.1016/j.ijrobp.2016.10.043 10.18632/oncotarget.23217 10.1038/ncponc0744 10.1016/0360-3016(79)90634-5 10.1016/S1470-2045(09)70082-8 10.1200/JCO.2018.36.15_suppl.6009 10.3109/02841869509127197 10.1158/2326-6066.CIR-17-0581 10.1098/rstb.2014.0231 10.1158/1078-0432.CCR-16-1432 10.1080/21645515.2015.1049779 10.1073/pnas.96.26.15074 10.1016/S1470-2045(18)30096-2 10.1002/pros.20794 10.1016/j.ccr.2009.06.017 10.1016/j.ijrobp.2005.06.032 10.1172/JCI67313 10.1200/JCO.2012.45.6400 10.1080/2162402X.2018.1477459 10.1038/sj.bjc.6602577 10.1158/2159-8290.CD-18-1495 10.1016/j.currproblcancer.2015.10.001 10.1158/0008-5472.CAN-12-3981 10.1038/ncomms15618 10.1016/S1470-2045(15)00054-6 10.1186/s12917-017-1126-0 10.1007/s10577-007-1212-4 10.1038/nature14292 10.1038/bjc.2013.365 10.1200/JCO.2017.75.1644 10.1186/s40425-019-0634-9 10.1016/j.radonc.2017.08.016 10.1200/JCO.2014.55.1366 10.1084/jem.20052494 10.1200/JCO.1996.14.8.2410 10.1038/s41591-018-0232-2 10.1016/S0140-6736(68)92672-X |
| ContentType | Journal Article |
| Copyright | 2020 The Authors Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2020 The Authors – notice: Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.ijrobp.2020.04.023 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-355X |
| EndPage | 16 |
| ExternalDocumentID | PMC7442714 32335187 10_1016_j_ijrobp_2020_04_023 S0360301620310439 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: P50 DE026787 – fundername: NIH HHS grantid: DP5 OD024576 – fundername: NCI NIH HHS grantid: U01 CA233102 – fundername: NCATS NIH HHS grantid: TL1 TR002375 – fundername: NIGMS NIH HHS grantid: T32 GM008692 – fundername: NCI NIH HHS grantid: P30 CA014520 |
| GroupedDBID | --- --K .1- .FO 0R~ 1B1 1P~ 1RT 1~5 4.4 457 4G. 53G 5RE 7-5 AAEDT AAEDW AALRI AAWTL AAXUO ABJNI ABLJU ABNEU ABOCM ABUDA ACGFS ACIUM ACVFH ADBBV ADCNI ADVLN AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AGCQF AHHHB AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY DU5 EBS EFKBS F5P FDB GBLVA HED HMO IHE J1W KOM LX3 M41 MO0 O9- OC~ OO- RNS ROL RPZ SDG SEL SES SSZ UV1 XH2 Z5R ~S- 6I. AAFTH AAIAV AFCTW AGZHU ALXNB EFJIC ZA5 .55 .GJ 29J 5VS AAQFI AAQQT AAQXK AAYWO AAYXX ABEFU ABWVN ACRPL ADMUD ADNMO AFFNX AFJKZ AGQPQ AGRDE ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB FIRID G-2 HMK HVGLF HX~ HZ~ NQ- R2- RIG SAE SEW UDS X7M XPP ZGI CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c516t-a2d343e994b9ec2ded06ebfe55ae6419b54a54e2f7e310dd6a8c54e69d2039193 |
| ISSN | 0360-3016 1879-355X |
| IngestDate | Thu Aug 21 14:11:29 EDT 2025 Mon Jul 21 11:03:01 EDT 2025 Mon Jul 21 06:02:15 EDT 2025 Tue Jul 01 01:09:56 EDT 2025 Thu Apr 24 23:02:28 EDT 2025 Fri Feb 23 02:49:23 EST 2024 Tue Aug 26 16:45:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c516t-a2d343e994b9ec2ded06ebfe55ae6419b54a54e2f7e310dd6a8c54e69d2039193 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.ijrobp.2020.04.023 |
| PMID | 32335187 |
| PQID | 2395258243 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7442714 proquest_miscellaneous_2395258243 pubmed_primary_32335187 crossref_primary_10_1016_j_ijrobp_2020_04_023 crossref_citationtrail_10_1016_j_ijrobp_2020_04_023 elsevier_sciencedirect_doi_10_1016_j_ijrobp_2020_04_023 elsevier_clinicalkey_doi_10_1016_j_ijrobp_2020_04_023 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-09-01 |
| PublicationDateYYYYMMDD | 2020-09-01 |
| PublicationDate_xml | – month: 09 year: 2020 text: 2020-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | International journal of radiation oncology, biology, physics |
| PublicationTitleAlternate | Int J Radiat Oncol Biol Phys |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Deng, Lian, Burnette (bib52) 2014; 124 Morris, Guy, Francis (bib48) 2016; 76 Dovedi, Cheadle, Popple (bib53) 2017; 23 Barker, Postow, Khan (bib59) 2013; 1 Harding, Benci, Irianto, Discher, Minn, Greenberg (bib40) 2017; 548 Paoloni, Davis, Lana (bib80) 2009; 10 Decker, Parker, Dhawan (bib79) 2015; 13 Ellsworth (bib33) 2018; 3 Schiffman, Breen (bib77) 2015; 370 Tsai, Fang-Hsin, Wang (bib27) 2007; 68 Tang, Welsh, de Groot (bib65) 2017; 23 Hamid, Robert, Daud (bib11) 2019; 30 Gordon, Paoloni, Mazcko, Khanna (bib82) 2009; 6 Sze, Grossman, Goddard (bib87) 2013; 109 Stone, Peters, Milas (bib1) 1979; 63 Abuodeh, Venkat, Kim (bib4) 2016; 40 Benci, Xu, Qiu (bib30) 2016; 167 Patel, Baniel, Sriramaneni, Bradley, Markovina, Morris (bib85) 2018; 17 Kroemer, Galluzzi, Kepp, Zitvogel (bib20) 2013; 31 Marciscano, Ghasemzadeh, Nirschl (bib86) 2018; 24 Diehl, Yarchoan, Hopkins, Jaffee, Grossman (bib34) 2017; 8 Kwon, Drake, Scher (bib64) 2014; 15 Reits, Hodge, Herberts (bib39) 2006; 203 Xu, Escamilla, Mok (bib28) 2013; 73 Gajewski (bib54) 2015; 42 Diamond, Vanpouille-Box, Spada (bib42) 2018; 6 Nakamura, Akiyama (bib44) 1990; 123 Fridlender, Sun, Kim (bib24) 2009; 16 Deng, Liang, Xu (bib41) 2014; 41 Waldmann (bib23) 2018; 10 Liang, Deng, Hou (bib29) 2017; 8 Vail, MacEwen (bib75) 2000; 18 Dewan, Galloway, Kawashima (bib35) 2009; 15 Kang, Demaria, Formenti (bib74) 2016; 4 LeBlanc, Breen, Choyke (bib81) 2016; 8 Hong, Ritter, Tome, Harari (bib8) 2005; 92 Rosen, Fan, Rockwell, Goldberg (bib32) 1999; 17 Martin, Cagney, Catalano (bib62) 2018; 4 Formenti, Demaria (bib3) 2009; 10 Rodriguez-Ruiz, Garasa, Rodriguez (bib22) 2017; 97 Kwon, Foster, Hurwitz (bib67) 1999; 96 Werner, Kler, Gressett (bib38) 2017; 124 Weichert, Clark, Kandela (bib89) 2014; 6 Liu (bib43) 2003; 1 Fyfe, Fisher, Rosenberg, Sznol, Parkinson, Louie (bib6) 1996; 14 Bentzen, Harari, Bernier (bib14) 2007; 4 Grapin, Richard, Limagne (bib36) 2019; 7 Steel (bib13) 1979; 5 Demaria, Kawashima, Yang (bib18) 2005; 11 Tanaka, Shinto, Yashiro (bib26) 2010; 24 Demaria, Bhardwaj, McBride, Formenti (bib15) 2005; 63 Liu, Sun, Luo (bib46) 2015; 5 Bach, Albertini, Joo, Anderson, Bortin (bib5) 1968; 2 Ahmed, Stallworth, Kim (bib60) 2016; 27 Fowler (bib37) 1989; 62 Bentebibel, Hurwitz, Bernatchez (bib73) 2019; 9 Breen, Modiano (bib78) 2008; 16 Gillies, Reilly, Lo, Reisfeld (bib56) 1992; 89 Blomgren, Lax, Naslund, Svanstrom (bib9) 1995; 34 Hernandez, Walker, Grudzinski (bib90) 2019; 2 Rekers, Zegers, Germeraad, Dubois, Lambin (bib57) 2015; 4 Harris, Hipkiss, Borzillary (bib63) 2008; 68 Theelen, Peulen, Lalezari (bib70) 2019; 5 Atkins, Lotze, Dutcher (bib7) 1999; 17 Twyman-Saint Victor, Rech, Maity (bib16) 2015; 520 Kaur, Asea (bib31) 2012; 2 Liu, Xiong, Zhang, Chu (bib45) 2010; 7 Gross, Waks, Eshhar (bib10) 1989; 86 Wu, Tsai, Lee (bib55) 2018; 7 Topalian, Hodi, Brahmer (bib12) 2019; 5 Baioni, Scanziani, Vincenti (bib76) 2017; 13 Vail, LeBlanc, Jeraj (bib83) 2020; 10 Demaria, Ng, Devitt (bib2) 2004; 58 Shaverdian, Lisberg, Bornazyan (bib61) 2017; 18 Antonia, Villegas, Daniel (bib66) 2017; 377 McBride, Sherman, Tsai (bib69) 2018; 36 Golden, Frances, Pellicciotta, Demaria, Helen Barcellos-Hoff, Formenti (bib21) 2014; 3 Hodi, Ballinger, Lyons (bib19) 2018; 36 Kachikwu, Iwamoto, Liao (bib25) 2011; 81 Campbell, Light, Fabrizio (bib51) 2017; 171 Pierce, Campbell, Pai, Brody, Kohrt (bib50) 2015; 11 Vanpouille-Box, Alard, Aryankalayil (bib17) 2017; 8 Marabelle, Tselikas, de Baere, Houot (bib49) 2017; 28 Nemunaitis (bib72) 2005; 4 Morschhauser, Radford, Van Hoof (bib88) 2013; 31 Golden, Chhabra, Chachoua (bib71) 2015; 16 Balogh, Persa, Bogdandi (bib47) 2013; 62 Formenti, Rudqvist, Golden (bib68) 2018; 24 Morris, Harari (bib84) 2014; 32 Niknam, Barsoumian, Schoenhals (bib58) 2018; 24 Bristow, Alexander, Baumann (bib91) 2018; 19 Deng (10.1016/j.ijrobp.2020.04.023_bib41) 2014; 41 Harris (10.1016/j.ijrobp.2020.04.023_bib63) 2008; 68 Kwon (10.1016/j.ijrobp.2020.04.023_bib67) 1999; 96 Morris (10.1016/j.ijrobp.2020.04.023_bib84) 2014; 32 Reits (10.1016/j.ijrobp.2020.04.023_bib39) 2006; 203 Nakamura (10.1016/j.ijrobp.2020.04.023_bib44) 1990; 123 Dewan (10.1016/j.ijrobp.2020.04.023_bib35) 2009; 15 Niknam (10.1016/j.ijrobp.2020.04.023_bib58) 2018; 24 Ahmed (10.1016/j.ijrobp.2020.04.023_bib60) 2016; 27 Blomgren (10.1016/j.ijrobp.2020.04.023_bib9) 1995; 34 Bentzen (10.1016/j.ijrobp.2020.04.023_bib14) 2007; 4 Diamond (10.1016/j.ijrobp.2020.04.023_bib42) 2018; 6 Harding (10.1016/j.ijrobp.2020.04.023_bib40) 2017; 548 Schiffman (10.1016/j.ijrobp.2020.04.023_bib77) 2015; 370 Bentebibel (10.1016/j.ijrobp.2020.04.023_bib73) 2019; 9 Gajewski (10.1016/j.ijrobp.2020.04.023_bib54) 2015; 42 Baioni (10.1016/j.ijrobp.2020.04.023_bib76) 2017; 13 Vail (10.1016/j.ijrobp.2020.04.023_bib83) 2020; 10 Kaur (10.1016/j.ijrobp.2020.04.023_bib31) 2012; 2 Topalian (10.1016/j.ijrobp.2020.04.023_bib12) 2019; 5 Vanpouille-Box (10.1016/j.ijrobp.2020.04.023_bib17) 2017; 8 Demaria (10.1016/j.ijrobp.2020.04.023_bib2) 2004; 58 Rodriguez-Ruiz (10.1016/j.ijrobp.2020.04.023_bib22) 2017; 97 Fyfe (10.1016/j.ijrobp.2020.04.023_bib6) 1996; 14 Twyman-Saint Victor (10.1016/j.ijrobp.2020.04.023_bib16) 2015; 520 Benci (10.1016/j.ijrobp.2020.04.023_bib30) 2016; 167 Abuodeh (10.1016/j.ijrobp.2020.04.023_bib4) 2016; 40 Golden (10.1016/j.ijrobp.2020.04.023_bib71) 2015; 16 Barker (10.1016/j.ijrobp.2020.04.023_bib59) 2013; 1 Shaverdian (10.1016/j.ijrobp.2020.04.023_bib61) 2017; 18 Weichert (10.1016/j.ijrobp.2020.04.023_bib89) 2014; 6 Morschhauser (10.1016/j.ijrobp.2020.04.023_bib88) 2013; 31 Hernandez (10.1016/j.ijrobp.2020.04.023_bib90) 2019; 2 Liu (10.1016/j.ijrobp.2020.04.023_bib45) 2010; 7 Fowler (10.1016/j.ijrobp.2020.04.023_bib37) 1989; 62 Demaria (10.1016/j.ijrobp.2020.04.023_bib18) 2005; 11 Tsai (10.1016/j.ijrobp.2020.04.023_bib27) 2007; 68 Wu (10.1016/j.ijrobp.2020.04.023_bib55) 2018; 7 Xu (10.1016/j.ijrobp.2020.04.023_bib28) 2013; 73 Atkins (10.1016/j.ijrobp.2020.04.023_bib7) 1999; 17 Ellsworth (10.1016/j.ijrobp.2020.04.023_bib33) 2018; 3 Marabelle (10.1016/j.ijrobp.2020.04.023_bib49) 2017; 28 Hong (10.1016/j.ijrobp.2020.04.023_bib8) 2005; 92 Hamid (10.1016/j.ijrobp.2020.04.023_bib11) 2019; 30 Bristow (10.1016/j.ijrobp.2020.04.023_bib91) 2018; 19 Formenti (10.1016/j.ijrobp.2020.04.023_bib68) 2018; 24 Kachikwu (10.1016/j.ijrobp.2020.04.023_bib25) 2011; 81 Martin (10.1016/j.ijrobp.2020.04.023_bib62) 2018; 4 Balogh (10.1016/j.ijrobp.2020.04.023_bib47) 2013; 62 Dovedi (10.1016/j.ijrobp.2020.04.023_bib53) 2017; 23 Pierce (10.1016/j.ijrobp.2020.04.023_bib50) 2015; 11 Waldmann (10.1016/j.ijrobp.2020.04.023_bib23) 2018; 10 Gillies (10.1016/j.ijrobp.2020.04.023_bib56) 1992; 89 Bach (10.1016/j.ijrobp.2020.04.023_bib5) 1968; 2 Kroemer (10.1016/j.ijrobp.2020.04.023_bib20) 2013; 31 Kwon (10.1016/j.ijrobp.2020.04.023_bib64) 2014; 15 Golden (10.1016/j.ijrobp.2020.04.023_bib21) 2014; 3 Diehl (10.1016/j.ijrobp.2020.04.023_bib34) 2017; 8 Stone (10.1016/j.ijrobp.2020.04.023_bib1) 1979; 63 Deng (10.1016/j.ijrobp.2020.04.023_bib52) 2014; 124 Steel (10.1016/j.ijrobp.2020.04.023_bib13) 1979; 5 Liang (10.1016/j.ijrobp.2020.04.023_bib29) 2017; 8 Gordon (10.1016/j.ijrobp.2020.04.023_bib82) 2009; 6 LeBlanc (10.1016/j.ijrobp.2020.04.023_bib81) 2016; 8 Hodi (10.1016/j.ijrobp.2020.04.023_bib19) 2018; 36 Decker (10.1016/j.ijrobp.2020.04.023_bib79) 2015; 13 Morris (10.1016/j.ijrobp.2020.04.023_bib48) 2016; 76 Formenti (10.1016/j.ijrobp.2020.04.023_bib3) 2009; 10 Fridlender (10.1016/j.ijrobp.2020.04.023_bib24) 2009; 16 Kang (10.1016/j.ijrobp.2020.04.023_bib74) 2016; 4 Gross (10.1016/j.ijrobp.2020.04.023_bib10) 1989; 86 Paoloni (10.1016/j.ijrobp.2020.04.023_bib80) 2009; 10 Marciscano (10.1016/j.ijrobp.2020.04.023_bib86) 2018; 24 Liu (10.1016/j.ijrobp.2020.04.023_bib43) 2003; 1 Tang (10.1016/j.ijrobp.2020.04.023_bib65) 2017; 23 Theelen (10.1016/j.ijrobp.2020.04.023_bib70) 2019; 5 Antonia (10.1016/j.ijrobp.2020.04.023_bib66) 2017; 377 Patel (10.1016/j.ijrobp.2020.04.023_bib85) 2018; 17 Rosen (10.1016/j.ijrobp.2020.04.023_bib32) 1999; 17 Liu (10.1016/j.ijrobp.2020.04.023_bib46) 2015; 5 Rekers (10.1016/j.ijrobp.2020.04.023_bib57) 2015; 4 Nemunaitis (10.1016/j.ijrobp.2020.04.023_bib72) 2005; 4 Tanaka (10.1016/j.ijrobp.2020.04.023_bib26) 2010; 24 Grapin (10.1016/j.ijrobp.2020.04.023_bib36) 2019; 7 Sze (10.1016/j.ijrobp.2020.04.023_bib87) 2013; 109 Vail (10.1016/j.ijrobp.2020.04.023_bib75) 2000; 18 Werner (10.1016/j.ijrobp.2020.04.023_bib38) 2017; 124 Campbell (10.1016/j.ijrobp.2020.04.023_bib51) 2017; 171 Breen (10.1016/j.ijrobp.2020.04.023_bib78) 2008; 16 Demaria (10.1016/j.ijrobp.2020.04.023_bib15) 2005; 63 McBride (10.1016/j.ijrobp.2020.04.023_bib69) 2018; 36 |
| References_xml | – volume: 24 start-page: 5735 year: 2018 end-page: 5743 ident: bib58 article-title: Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model publication-title: Clin Cancer Res – volume: 8 start-page: 324ps5 year: 2016 ident: bib81 article-title: Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology publication-title: Sci Transl Med – volume: 520 start-page: 373 year: 2015 end-page: 377 ident: bib16 article-title: Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer publication-title: Nature – volume: 4 year: 2015 ident: bib57 article-title: Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2 publication-title: Oncoimmunology – volume: 5 start-page: 1145 year: 1979 end-page: 1150 ident: bib13 article-title: Terminology in the description of drug-radiation interactions publication-title: Int J Radiat Oncol Biol Phys – volume: 36 start-page: 850 year: 2018 end-page: 858 ident: bib19 article-title: Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy publication-title: J Clin Oncol – volume: 15 start-page: 5379 year: 2009 end-page: 5388 ident: bib35 article-title: Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody publication-title: Clin Cancer Res – volume: 171 start-page: 1042 year: 2017 end-page: 1056.e10 ident: bib51 article-title: Comprehensive analysis of hypermutation in human cancer publication-title: Cell – volume: 8 start-page: 114268 year: 2017 end-page: 114280 ident: bib34 article-title: Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors publication-title: Oncotarget – volume: 9 start-page: 711 year: 2019 end-page: 721 ident: bib73 article-title: A first-in-human study and biomarker analysis of NKTR-214, a novel IL2Rbetagamma-biased cytokine, in patients with advanced or metastatic solid tumors publication-title: Cancer Discov – volume: 16 start-page: 183 year: 2009 end-page: 194 ident: bib24 article-title: Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN publication-title: Cancer Cell – volume: 81 start-page: 1128 year: 2011 end-page: 1135 ident: bib25 article-title: Radiation enhances regulatory T cell representation publication-title: Int J Radiat Oncol Biol Phys – volume: 2 start-page: 191 year: 2012 ident: bib31 article-title: Radiation-induced effects and the immune system in cancer publication-title: Front Oncol – volume: 36 start-page: 6009 year: 2018 ident: bib69 article-title: A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC) publication-title: J Clin Oncol – volume: 23 start-page: 1388 year: 2017 end-page: 1396 ident: bib65 article-title: Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T Cells publication-title: Clin Cancer Res – volume: 17 start-page: 2105 year: 1999 end-page: 2116 ident: bib7 article-title: High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 publication-title: J Clin Oncol – volume: 27 start-page: 434 year: 2016 end-page: 441 ident: bib60 article-title: Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy publication-title: Ann Oncol – volume: 18 start-page: 781 year: 2000 end-page: 792 ident: bib75 article-title: Spontaneously occurring tumors of companion animals as models for human cancer publication-title: Cancer Invest – volume: 89 start-page: 1428 year: 1992 end-page: 1432 ident: bib56 article-title: Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells publication-title: Proc Natl Acad Sci USA – volume: 17 start-page: 995 year: 2018 end-page: 1003 ident: bib85 article-title: Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities publication-title: Brachytherapy – volume: 68 start-page: 499 year: 2007 end-page: 507 ident: bib27 article-title: Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth publication-title: Int J Radiat Oncol Biol Phys – volume: 16 start-page: 145 year: 2008 end-page: 154 ident: bib78 article-title: Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans—man and his best friend share more than companionship publication-title: Chromosome Res – volume: 73 start-page: 2782 year: 2013 end-page: 2794 ident: bib28 article-title: CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer publication-title: Cancer Res – volume: 370 start-page: 20140231 year: 2015 ident: bib77 article-title: Comparative oncology: What dogs and other species can teach us about humans with cancer publication-title: Philos Trans R Soc Lond B Biol Sci – volume: 76 start-page: 3929 year: 2016 end-page: 3941 ident: bib48 article-title: In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments publication-title: Cancer Res – volume: 24 start-page: 1845 year: 2018 end-page: 1851 ident: bib68 article-title: Radiotherapy induces responses of lung cancer to CTLA-4 blockade publication-title: Nat Med – volume: 2 start-page: 79 year: 2019 ident: bib90 article-title: (90)Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma publication-title: Commun Biol – volume: 8 start-page: 15618 year: 2017 ident: bib17 article-title: DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity publication-title: Nat Commun – volume: 63 start-page: 1229 year: 1979 end-page: 1235 ident: bib1 article-title: Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma publication-title: J Natl Cancer Inst – volume: 123 start-page: 224 year: 1990 end-page: 227 ident: bib44 article-title: Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay publication-title: Radiat Res – volume: 19 start-page: e240 year: 2018 end-page: e251 ident: bib91 article-title: Combining precision radiotherapy with molecular targeting and immunomodulatory agents: A guideline by the American Society for Radiation Oncology publication-title: Lancet Oncol – volume: 167 start-page: 1540 year: 2016 end-page: 1554.e12 ident: bib30 article-title: Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade publication-title: Cell – volume: 4 start-page: 1123 year: 2018 end-page: 1124 ident: bib62 article-title: Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation publication-title: JAMA Oncol – volume: 62 start-page: 679 year: 1989 end-page: 694 ident: bib37 article-title: The linear-quadratic formula and progress in fractionated radiotherapy publication-title: Br J Radiol – volume: 10 start-page: 718 year: 2009 end-page: 726 ident: bib3 article-title: Systemic effects of local radiotherapy publication-title: Lancet Oncol – volume: 3 start-page: 512 year: 2018 end-page: 519 ident: bib33 article-title: Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors publication-title: Adv Radiat Oncol – volume: 10 start-page: 625 year: 2009 ident: bib80 article-title: Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression publication-title: BMC Genomics – volume: 97 start-page: 389 year: 2017 end-page: 400 ident: bib22 article-title: Intercellular adhesion molecule-1 and vascular cell adhesion molecule are induced by ionizing radiation on lymphatic endothelium publication-title: Int J Radiat Oncol Biol Phys – volume: 11 start-page: 1901 year: 2015 end-page: 1909 ident: bib50 article-title: In-situ tumor vaccination: Bringing the fight to the tumor publication-title: Hum Vaccin Immunother – volume: 42 start-page: 663 year: 2015 end-page: 671 ident: bib54 article-title: The next hurdle in cancer immunotherapy: Overcoming the non-T-cell-inflamed tumor microenvironment publication-title: Semin Oncol – volume: 5 start-page: 1411 year: 2019 end-page: 1420 ident: bib12 article-title: Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab publication-title: JAMA Oncol – volume: 5 start-page: 1276 year: 2019 end-page: 1282 ident: bib70 article-title: Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: Results of the PEMBRO-RT phase 2 randomized clinical Trial publication-title: JAMA Oncol – volume: 11 start-page: 728 year: 2005 end-page: 734 ident: bib18 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin Cancer Res – volume: 8 start-page: 1736 year: 2017 ident: bib29 article-title: Host STING-dependent MDSC mobilization drives extrinsic radiation resistance publication-title: Nat Commun – volume: 7 start-page: 160 year: 2019 ident: bib36 article-title: Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: A promising new combination publication-title: J Immunother Cancer – volume: 4 start-page: 259 year: 2005 end-page: 274 ident: bib72 article-title: Vaccines in cancer: GVAX, a GM-CSF gene vaccine publication-title: Expert Rev Vaccines – volume: 14 start-page: 2410 year: 1996 end-page: 2411 ident: bib6 article-title: Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy publication-title: J Clin Oncol – volume: 92 start-page: 1819 year: 2005 end-page: 1824 ident: bib8 article-title: Intensity-modulated radiation therapy: Emerging cancer treatment technology publication-title: Br J Cancer – volume: 34 start-page: 861 year: 1995 end-page: 870 ident: bib9 article-title: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients publication-title: Acta Oncol – volume: 32 start-page: 2886 year: 2014 end-page: 2893 ident: bib84 article-title: Interaction of radiation therapy with molecular targeted agents publication-title: J Clin Oncol – volume: 15 start-page: 700 year: 2014 end-page: 712 ident: bib64 article-title: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial publication-title: Lancet Oncol – volume: 109 start-page: 565 year: 2013 end-page: 572 ident: bib87 article-title: Sequelae and survivorship in patients treated with (131)I-MIBG therapy publication-title: Br J Cancer – volume: 86 start-page: 10024 year: 1989 end-page: 10028 ident: bib10 article-title: Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity publication-title: Proc Natl Acad Sci USA – volume: 1 start-page: 92 year: 2013 end-page: 98 ident: bib59 article-title: Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma publication-title: Cancer Immunol Res – volume: 1 start-page: 71 year: 2003 end-page: 92 ident: bib43 article-title: Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: Mechanisms and implications publication-title: Nonlinearity Biol Toxicol Med – volume: 2 start-page: 1364 year: 1968 end-page: 1366 ident: bib5 article-title: Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome publication-title: Lancet – volume: 10 start-page: 84 year: 2020 ident: bib83 article-title: Advanced cancer imaging applied in the comparative setting publication-title: Front Oncol – volume: 13 start-page: 203 year: 2017 ident: bib76 article-title: Estimating canine cancer incidence: Findings from a population-based tumour registry in northwestern Italy publication-title: BMC Vet Res – volume: 40 start-page: 25 year: 2016 end-page: 37 ident: bib4 article-title: Systematic review of case reports on the abscopal effect publication-title: Curr Probl Cancer – volume: 96 start-page: 15074 year: 1999 end-page: 15079 ident: bib67 article-title: Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy publication-title: Proc Natl Acad Sci USA – volume: 124 start-page: 687 year: 2014 end-page: 695 ident: bib52 article-title: Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice publication-title: J Clin Invest – volume: 63 start-page: 655 year: 2005 end-page: 666 ident: bib15 article-title: Combining radiotherapy and immunotherapy: A revived partnership publication-title: Int J Radiat Oncol Biol Phys – volume: 30 start-page: 582 year: 2019 end-page: 588 ident: bib11 article-title: Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 publication-title: Ann Oncol – volume: 3 year: 2014 ident: bib21 article-title: Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death publication-title: Oncoimmunology – volume: 203 start-page: 1259 year: 2006 end-page: 1271 ident: bib39 article-title: Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy publication-title: J Exp Med – volume: 6 start-page: 910 year: 2018 end-page: 920 ident: bib42 article-title: Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs publication-title: Cancer Immunol Res – volume: 548 start-page: 466 year: 2017 end-page: 470 ident: bib40 article-title: Mitotic progression following DNA damage enables pattern recognition within micronuclei publication-title: Nature – volume: 16 start-page: 795 year: 2015 end-page: 803 ident: bib71 article-title: Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: A proof-of-principle trial publication-title: Lancet Oncol – volume: 6 year: 2014 ident: bib89 article-title: Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy publication-title: Sci Transl Med – volume: 24 start-page: 1637 year: 2010 end-page: 1643 ident: bib26 article-title: Transforming growth factor beta signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity publication-title: Oncol Rep – volume: 5 start-page: 3276 year: 2015 end-page: 3285 ident: bib46 article-title: Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications publication-title: Am J Cancer Res – volume: 13 start-page: 993 year: 2015 end-page: 1002 ident: bib79 article-title: Homologous mutation to human BRAF V600E Is common in naturally occurring canine bladder cancer—evidence for a relevant model system and urine-based diagnostic test publication-title: Mol Cancer Res – volume: 7 year: 2018 ident: bib55 article-title: Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment publication-title: Oncoimmunology – volume: 28 start-page: xii33 year: 2017 end-page: xii43 ident: bib49 article-title: Intratumoral immunotherapy: Using the tumor as the remedy publication-title: Ann Oncol – volume: 58 start-page: 862 year: 2004 end-page: 870 ident: bib2 article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated publication-title: Int J Radiat Oncol Biol Phys – volume: 4 start-page: 172 year: 2007 end-page: 180 ident: bib14 article-title: Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions publication-title: Nat Clin Pract Oncol – volume: 31 start-page: 1977 year: 2013 end-page: 1983 ident: bib88 article-title: 90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: Updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial publication-title: J Clin Oncol – volume: 62 start-page: 201 year: 2013 end-page: 212 ident: bib47 article-title: The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells publication-title: Inflamm Res – volume: 18 start-page: 895 year: 2017 end-page: 903 ident: bib61 article-title: Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: A secondary analysis of the KEYNOTE-001 phase 1 trial publication-title: Lancet Oncol – volume: 41 start-page: 843 year: 2014 end-page: 852 ident: bib41 article-title: STING-dependent cytosolic DNA sensing promotes radiation-induced type i interferon-dependent antitumor immunity in immunogenic tumors publication-title: Immunity – volume: 17 start-page: 56 year: 1999 end-page: 72 ident: bib32 article-title: The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation publication-title: Cancer Invest – volume: 4 start-page: 51 year: 2016 ident: bib74 article-title: Current clinical trials testing the combination of immunotherapy with radiotherapy publication-title: J Immunother Cancer – volume: 68 start-page: 1319 year: 2008 end-page: 1329 ident: bib63 article-title: Radiotherapy augments the immune response to prostate cancer in a time-dependent manner publication-title: Prostate – volume: 10 start-page: a028472 year: 2018 ident: bib23 article-title: Cytokines in cancer immunotherapy publication-title: Cold Spring Harb Perspect Biol – volume: 124 start-page: 418 year: 2017 end-page: 426 ident: bib38 article-title: Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma publication-title: Radiother Oncol – volume: 24 start-page: 5058 year: 2018 end-page: 5071 ident: bib86 article-title: Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy publication-title: Clin Cancer Res – volume: 31 start-page: 51 year: 2013 end-page: 72 ident: bib20 article-title: Immunogenic cell death in cancer therapy publication-title: Annu Rev Immunol – volume: 377 start-page: 1919 year: 2017 end-page: 1929 ident: bib66 article-title: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer publication-title: N Engl J Med – volume: 23 start-page: 5514 year: 2017 end-page: 5526 ident: bib53 article-title: Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade publication-title: Clin Cancer Res – volume: 7 start-page: 157 year: 2010 end-page: 162 ident: bib45 article-title: Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells publication-title: Cell Mol Immunol – volume: 6 year: 2009 ident: bib82 article-title: The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway publication-title: PLoS Med – volume: 4 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib57 article-title: Long-lasting antitumor effects provided by radiotherapy combined with the immunocytokine L19-IL2 publication-title: Oncoimmunology doi: 10.1080/2162402X.2015.1021541 – volume: 15 start-page: 700 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib64 article-title: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(14)70189-5 – volume: 68 start-page: 499 year: 2007 ident: 10.1016/j.ijrobp.2020.04.023_bib27 article-title: Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2007.01.041 – volume: 17 start-page: 56 year: 1999 ident: 10.1016/j.ijrobp.2020.04.023_bib32 article-title: The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation publication-title: Cancer Invest doi: 10.1080/07357909909011718 – volume: 5 start-page: 1276 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib70 article-title: Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: Results of the PEMBRO-RT phase 2 randomized clinical Trial publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.1478 – volume: 76 start-page: 3929 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib48 article-title: In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-2644 – volume: 6 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib89 article-title: Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3007646 – volume: 10 start-page: a028472 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib23 article-title: Cytokines in cancer immunotherapy publication-title: Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a028472 – volume: 2 start-page: 191 year: 2012 ident: 10.1016/j.ijrobp.2020.04.023_bib31 article-title: Radiation-induced effects and the immune system in cancer publication-title: Front Oncol doi: 10.3389/fonc.2012.00191 – volume: 62 start-page: 679 year: 1989 ident: 10.1016/j.ijrobp.2020.04.023_bib37 article-title: The linear-quadratic formula and progress in fractionated radiotherapy publication-title: Br J Radiol doi: 10.1259/0007-1285-62-740-679 – volume: 8 start-page: 1736 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib29 article-title: Host STING-dependent MDSC mobilization drives extrinsic radiation resistance publication-title: Nat Commun doi: 10.1038/s41467-017-01566-5 – volume: 28 start-page: xii33 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib49 article-title: Intratumoral immunotherapy: Using the tumor as the remedy publication-title: Ann Oncol doi: 10.1093/annonc/mdx683 – volume: 10 start-page: 625 year: 2009 ident: 10.1016/j.ijrobp.2020.04.023_bib80 article-title: Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression publication-title: BMC Genomics doi: 10.1186/1471-2164-10-625 – volume: 58 start-page: 862 year: 2004 ident: 10.1016/j.ijrobp.2020.04.023_bib2 article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2003.09.012 – volume: 4 start-page: 259 year: 2005 ident: 10.1016/j.ijrobp.2020.04.023_bib72 article-title: Vaccines in cancer: GVAX, a GM-CSF gene vaccine publication-title: Expert Rev Vaccines doi: 10.1586/14760584.4.3.259 – volume: 2 start-page: 79 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib90 article-title: (90)Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma publication-title: Commun Biol doi: 10.1038/s42003-019-0327-4 – volume: 11 start-page: 728 year: 2005 ident: 10.1016/j.ijrobp.2020.04.023_bib18 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.728.11.2 – volume: 24 start-page: 5735 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib58 article-title: Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-3279 – volume: 62 start-page: 201 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib47 article-title: The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells publication-title: Inflamm Res doi: 10.1007/s00011-012-0567-y – volume: 15 start-page: 5379 year: 2009 ident: 10.1016/j.ijrobp.2020.04.023_bib35 article-title: Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-0265 – volume: 377 start-page: 1919 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib66 article-title: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1709937 – volume: 30 start-page: 582 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib11 article-title: Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 publication-title: Ann Oncol doi: 10.1093/annonc/mdz011 – volume: 6 year: 2009 ident: 10.1016/j.ijrobp.2020.04.023_bib82 article-title: The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway publication-title: PLoS Med doi: 10.1371/journal.pmed.1000161 – volume: 10 start-page: 84 year: 2020 ident: 10.1016/j.ijrobp.2020.04.023_bib83 article-title: Advanced cancer imaging applied in the comparative setting publication-title: Front Oncol doi: 10.3389/fonc.2020.00084 – volume: 31 start-page: 51 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib20 article-title: Immunogenic cell death in cancer therapy publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-032712-100008 – volume: 123 start-page: 224 year: 1990 ident: 10.1016/j.ijrobp.2020.04.023_bib44 article-title: Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay publication-title: Radiat Res doi: 10.2307/3577549 – volume: 17 start-page: 995 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib85 article-title: Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities publication-title: Brachytherapy doi: 10.1016/j.brachy.2018.07.004 – volume: 41 start-page: 843 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib41 article-title: STING-dependent cytosolic DNA sensing promotes radiation-induced type i interferon-dependent antitumor immunity in immunogenic tumors publication-title: Immunity doi: 10.1016/j.immuni.2014.10.019 – volume: 24 start-page: 5058 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib86 article-title: Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-3427 – volume: 13 start-page: 993 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib79 article-title: Homologous mutation to human BRAF V600E Is common in naturally occurring canine bladder cancer—evidence for a relevant model system and urine-based diagnostic test publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-14-0689 – volume: 24 start-page: 1637 year: 2010 ident: 10.1016/j.ijrobp.2020.04.023_bib26 article-title: Transforming growth factor beta signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity publication-title: Oncol Rep doi: 10.3892/or_00001028 – volume: 3 start-page: 512 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib33 article-title: Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors publication-title: Adv Radiat Oncol doi: 10.1016/j.adro.2018.08.014 – volume: 167 start-page: 1540 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib30 article-title: Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade publication-title: Cell doi: 10.1016/j.cell.2016.11.022 – volume: 18 start-page: 781 year: 2000 ident: 10.1016/j.ijrobp.2020.04.023_bib75 article-title: Spontaneously occurring tumors of companion animals as models for human cancer publication-title: Cancer Invest doi: 10.3109/07357900009012210 – volume: 86 start-page: 10024 year: 1989 ident: 10.1016/j.ijrobp.2020.04.023_bib10 article-title: Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.24.10024 – volume: 7 start-page: 157 year: 2010 ident: 10.1016/j.ijrobp.2020.04.023_bib45 article-title: Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells publication-title: Cell Mol Immunol doi: 10.1038/cmi.2009.117 – volume: 1 start-page: 71 year: 2003 ident: 10.1016/j.ijrobp.2020.04.023_bib43 article-title: Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: Mechanisms and implications publication-title: Nonlinearity Biol Toxicol Med doi: 10.1080/15401420390844483 – volume: 81 start-page: 1128 year: 2011 ident: 10.1016/j.ijrobp.2020.04.023_bib25 article-title: Radiation enhances regulatory T cell representation publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2010.09.034 – volume: 42 start-page: 663 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib54 article-title: The next hurdle in cancer immunotherapy: Overcoming the non-T-cell-inflamed tumor microenvironment publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2015.05.011 – volume: 171 start-page: 1042 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib51 article-title: Comprehensive analysis of hypermutation in human cancer publication-title: Cell doi: 10.1016/j.cell.2017.09.048 – volume: 1 start-page: 92 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib59 article-title: Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-13-0082 – volume: 18 start-page: 895 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib61 article-title: Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: A secondary analysis of the KEYNOTE-001 phase 1 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30380-7 – volume: 23 start-page: 5514 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib53 article-title: Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-16-1673 – volume: 548 start-page: 466 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib40 article-title: Mitotic progression following DNA damage enables pattern recognition within micronuclei publication-title: Nature doi: 10.1038/nature23470 – volume: 27 start-page: 434 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib60 article-title: Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy publication-title: Ann Oncol doi: 10.1093/annonc/mdv622 – volume: 4 start-page: 51 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib74 article-title: Current clinical trials testing the combination of immunotherapy with radiotherapy publication-title: J Immunother Cancer doi: 10.1186/s40425-016-0156-7 – volume: 17 start-page: 2105 year: 1999 ident: 10.1016/j.ijrobp.2020.04.023_bib7 article-title: High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 publication-title: J Clin Oncol doi: 10.1200/JCO.1999.17.7.2105 – volume: 4 start-page: 1123 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib62 article-title: Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.3993 – volume: 3 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib21 article-title: Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death publication-title: Oncoimmunology doi: 10.4161/onci.28518 – volume: 8 start-page: 324ps5 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib81 article-title: Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaf0746 – volume: 5 start-page: 1411 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib12 article-title: Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.2187 – volume: 89 start-page: 1428 year: 1992 ident: 10.1016/j.ijrobp.2020.04.023_bib56 article-title: Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.4.1428 – volume: 97 start-page: 389 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib22 article-title: Intercellular adhesion molecule-1 and vascular cell adhesion molecule are induced by ionizing radiation on lymphatic endothelium publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2016.10.043 – volume: 8 start-page: 114268 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib34 article-title: Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors publication-title: Oncotarget doi: 10.18632/oncotarget.23217 – volume: 4 start-page: 172 year: 2007 ident: 10.1016/j.ijrobp.2020.04.023_bib14 article-title: Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions publication-title: Nat Clin Pract Oncol doi: 10.1038/ncponc0744 – volume: 5 start-page: 1145 year: 1979 ident: 10.1016/j.ijrobp.2020.04.023_bib13 article-title: Terminology in the description of drug-radiation interactions publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(79)90634-5 – volume: 10 start-page: 718 year: 2009 ident: 10.1016/j.ijrobp.2020.04.023_bib3 article-title: Systemic effects of local radiotherapy publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70082-8 – volume: 36 start-page: 6009 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib69 article-title: A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC) publication-title: J Clin Oncol doi: 10.1200/JCO.2018.36.15_suppl.6009 – volume: 34 start-page: 861 year: 1995 ident: 10.1016/j.ijrobp.2020.04.023_bib9 article-title: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients publication-title: Acta Oncol doi: 10.3109/02841869509127197 – volume: 6 start-page: 910 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib42 article-title: Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-17-0581 – volume: 370 start-page: 20140231 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib77 article-title: Comparative oncology: What dogs and other species can teach us about humans with cancer publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2014.0231 – volume: 23 start-page: 1388 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib65 article-title: Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T Cells publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-16-1432 – volume: 11 start-page: 1901 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib50 article-title: In-situ tumor vaccination: Bringing the fight to the tumor publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2015.1049779 – volume: 96 start-page: 15074 year: 1999 ident: 10.1016/j.ijrobp.2020.04.023_bib67 article-title: Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.26.15074 – volume: 19 start-page: e240 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib91 article-title: Combining precision radiotherapy with molecular targeting and immunomodulatory agents: A guideline by the American Society for Radiation Oncology publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30096-2 – volume: 68 start-page: 1319 year: 2008 ident: 10.1016/j.ijrobp.2020.04.023_bib63 article-title: Radiotherapy augments the immune response to prostate cancer in a time-dependent manner publication-title: Prostate doi: 10.1002/pros.20794 – volume: 16 start-page: 183 year: 2009 ident: 10.1016/j.ijrobp.2020.04.023_bib24 article-title: Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.06.017 – volume: 5 start-page: 3276 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib46 article-title: Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications publication-title: Am J Cancer Res – volume: 63 start-page: 655 year: 2005 ident: 10.1016/j.ijrobp.2020.04.023_bib15 article-title: Combining radiotherapy and immunotherapy: A revived partnership publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2005.06.032 – volume: 124 start-page: 687 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib52 article-title: Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice publication-title: J Clin Invest doi: 10.1172/JCI67313 – volume: 31 start-page: 1977 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib88 article-title: 90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: Updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial publication-title: J Clin Oncol doi: 10.1200/JCO.2012.45.6400 – volume: 7 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib55 article-title: Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment publication-title: Oncoimmunology doi: 10.1080/2162402X.2018.1477459 – volume: 92 start-page: 1819 year: 2005 ident: 10.1016/j.ijrobp.2020.04.023_bib8 article-title: Intensity-modulated radiation therapy: Emerging cancer treatment technology publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602577 – volume: 9 start-page: 711 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib73 article-title: A first-in-human study and biomarker analysis of NKTR-214, a novel IL2Rbetagamma-biased cytokine, in patients with advanced or metastatic solid tumors publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-18-1495 – volume: 40 start-page: 25 year: 2016 ident: 10.1016/j.ijrobp.2020.04.023_bib4 article-title: Systematic review of case reports on the abscopal effect publication-title: Curr Probl Cancer doi: 10.1016/j.currproblcancer.2015.10.001 – volume: 73 start-page: 2782 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib28 article-title: CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-3981 – volume: 8 start-page: 15618 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib17 article-title: DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity publication-title: Nat Commun doi: 10.1038/ncomms15618 – volume: 16 start-page: 795 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib71 article-title: Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: A proof-of-principle trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00054-6 – volume: 13 start-page: 203 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib76 article-title: Estimating canine cancer incidence: Findings from a population-based tumour registry in northwestern Italy publication-title: BMC Vet Res doi: 10.1186/s12917-017-1126-0 – volume: 16 start-page: 145 year: 2008 ident: 10.1016/j.ijrobp.2020.04.023_bib78 article-title: Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans—man and his best friend share more than companionship publication-title: Chromosome Res doi: 10.1007/s10577-007-1212-4 – volume: 520 start-page: 373 year: 2015 ident: 10.1016/j.ijrobp.2020.04.023_bib16 article-title: Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer publication-title: Nature doi: 10.1038/nature14292 – volume: 109 start-page: 565 year: 2013 ident: 10.1016/j.ijrobp.2020.04.023_bib87 article-title: Sequelae and survivorship in patients treated with (131)I-MIBG therapy publication-title: Br J Cancer doi: 10.1038/bjc.2013.365 – volume: 36 start-page: 850 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib19 article-title: Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy publication-title: J Clin Oncol doi: 10.1200/JCO.2017.75.1644 – volume: 7 start-page: 160 year: 2019 ident: 10.1016/j.ijrobp.2020.04.023_bib36 article-title: Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: A promising new combination publication-title: J Immunother Cancer doi: 10.1186/s40425-019-0634-9 – volume: 124 start-page: 418 year: 2017 ident: 10.1016/j.ijrobp.2020.04.023_bib38 article-title: Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma publication-title: Radiother Oncol doi: 10.1016/j.radonc.2017.08.016 – volume: 32 start-page: 2886 year: 2014 ident: 10.1016/j.ijrobp.2020.04.023_bib84 article-title: Interaction of radiation therapy with molecular targeted agents publication-title: J Clin Oncol doi: 10.1200/JCO.2014.55.1366 – volume: 203 start-page: 1259 year: 2006 ident: 10.1016/j.ijrobp.2020.04.023_bib39 article-title: Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy publication-title: J Exp Med doi: 10.1084/jem.20052494 – volume: 63 start-page: 1229 year: 1979 ident: 10.1016/j.ijrobp.2020.04.023_bib1 article-title: Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma publication-title: J Natl Cancer Inst – volume: 14 start-page: 2410 year: 1996 ident: 10.1016/j.ijrobp.2020.04.023_bib6 article-title: Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy publication-title: J Clin Oncol doi: 10.1200/JCO.1996.14.8.2410 – volume: 24 start-page: 1845 year: 2018 ident: 10.1016/j.ijrobp.2020.04.023_bib68 article-title: Radiotherapy induces responses of lung cancer to CTLA-4 blockade publication-title: Nat Med doi: 10.1038/s41591-018-0232-2 – volume: 2 start-page: 1364 year: 1968 ident: 10.1016/j.ijrobp.2020.04.023_bib5 article-title: Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome publication-title: Lancet doi: 10.1016/S0140-6736(68)92672-X |
| SSID | ssj0001174 |
| Score | 2.6092253 |
| SecondaryResourceType | review_article |
| Snippet | The development of immunotherapy in oncology builds upon many years of scientific investigation into the cellular mechanics underlying interactions between... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 6 |
| SubjectTerms | Combined Modality Therapy Humans Immunotherapy Radiotherapy Randomized Controlled Trials as Topic Translational Research, Biomedical |
| Title | The Promise of Combining Radiation Therapy With Immunotherapy |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0360301620310439 https://dx.doi.org/10.1016/j.ijrobp.2020.04.023 https://www.ncbi.nlm.nih.gov/pubmed/32335187 https://www.proquest.com/docview/2395258243 https://pubmed.ncbi.nlm.nih.gov/PMC7442714 |
| Volume | 108 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZLAiGX0nfTFy70tnixZUm2jmFpSRu2hLChoRdjPUyztHZwdy_9Af3dHVmPtbstSXMxu7Yl2_rGoxl55huE3lZCikqldcyYlDGpCxFzoUQsVUKl0ljhPpF28YmdXJCPl_RyMvk1iFrarMVM_vxrXsldUIV9gKvJkv0PZEOnsAN-A76wBYRhe2uMz7oWoOo9f3i3RV_vYXpuGAd6ZJeWNcCut34wySAu5Wr0OXe8Ljhgk-hCR20jQ2KL2Oa42JWRbRxiBX6uKYZtCyGbUmHNdD7b6jnjm_uIxOkiHFi0XWfZDr5UJhEMNNpsuCAB3qePuNomYoFqT1LHcG31apHzGEyby5HiTYodCbNqlA3mY9vPjqa3iw6r2dWqa4UhHsVJz1lrs5cH4F9_79HPcJbR1E3uY4bts8U8JwTnph76PgZ3A_Tl_vHp-efTMKenjs_bP5pPwuwjBXdv4RAd-Ov9y97Z9Wf-DMsd2DnL--iec1CiYyttD9BENw_RwcKFYDxCRugiJ3RRW0dB6KIgdJETusgIXTQSusfo4v275fwkdjU4YklTto4rrDKSac6J4FpipVXCtKg1pZVmJOWCkooSjetcg6OgFKsKCf8ZV9jUHuDZE7TXtI1-hqKCgFogYDErzIlUFc9qliU6z4zXTBg-QpkfqVI6gnpTJ-Vb6SMRV6Ud6tIMdZmQEob6CMWh1bUlaLnhfOpBKH3yMUyXJcjVDe3y0M4Zp9bovEXLNx7rErAxH-SqRrebHyXOOMW0wATOeWqxD8_g5QeuO5KKcILhhR8faa6-9vzwTpif37nlC3S4fbFfor11t9GvwPZei9fuxfgNAFbdsQ |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Promise+of+Combining+Radiation+Therapy+with+Immunotherapy&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Jagodinsky%2C+Justin+C.&rft.au=Harari%2C+Paul+M.&rft.au=Morris%2C+Zachary+S.&rft.date=2020-09-01&rft.issn=0360-3016&rft.eissn=1879-355X&rft.volume=108&rft.issue=1&rft.spage=6&rft.epage=16&rft_id=info:doi/10.1016%2Fj.ijrobp.2020.04.023&rft_id=info%3Apmid%2F32335187&rft.externalDocID=PMC7442714 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon |